Fei Mao

472 total citations
15 papers, 348 citations indexed

About

Fei Mao is a scholar working on Physiology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Fei Mao has authored 15 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 7 papers in Epidemiology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Fei Mao's work include Liver Disease Diagnosis and Treatment (5 papers), Pain Mechanisms and Treatments (3 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). Fei Mao is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Pain Mechanisms and Treatments (3 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). Fei Mao collaborates with scholars based in China, United States and Canada. Fei Mao's co-authors include Siying Liu, Hangping Zheng, Xiaoming Zhu, Bin Lü, Yiming Li, Shuo Zhang, Hongli Shi, Yiming Li, Xiaona Qiao and Zhaoyun Zhang and has published in prestigious journals such as Scientific Reports, Journal of Hepatology and Life Sciences.

In The Last Decade

Fei Mao

15 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fei Mao China 8 139 94 89 79 68 15 348
Melanie J. Mittenbühler Germany 5 128 0.9× 39 0.4× 38 0.4× 103 1.3× 38 0.6× 6 385
Da Mi Kim United States 11 76 0.5× 64 0.7× 69 0.8× 72 0.9× 15 0.2× 25 392
Miwa Morita Japan 11 42 0.3× 95 1.0× 26 0.3× 53 0.7× 48 0.7× 17 349
Pijun Yan China 15 186 1.3× 123 1.3× 26 0.3× 213 2.7× 55 0.8× 44 603
Andrea Del Buono Italy 9 88 0.6× 171 1.8× 16 0.2× 38 0.5× 67 1.0× 19 401
Mizuki Endo Japan 8 65 0.5× 74 0.8× 28 0.3× 180 2.3× 27 0.4× 26 374
Xiaojie Li China 12 55 0.4× 28 0.3× 18 0.2× 58 0.7× 44 0.6× 35 437
Shaishav Dhage United Kingdom 14 143 1.0× 81 0.9× 58 0.7× 40 0.5× 9 0.1× 29 446
Hannah Seok South Korea 10 72 0.5× 73 0.8× 9 0.1× 32 0.4× 64 0.9× 20 315
De-hong Cai China 11 71 0.5× 160 1.7× 43 0.5× 46 0.6× 12 0.2× 29 354

Countries citing papers authored by Fei Mao

Since Specialization
Citations

This map shows the geographic impact of Fei Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Mao more than expected).

Fields of papers citing papers by Fei Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Mao. The network helps show where Fei Mao may publish in the future.

Co-authorship network of co-authors of Fei Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Mao. A scholar is included among the top collaborators of Fei Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Mao. Fei Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Mao, Fei, et al.. (2024). Identification of pyroptosis-related gene signature in nonalcoholic steatohepatitis. Scientific Reports. 14(1). 3175–3175. 4 indexed citations
2.
Xu, Jing, et al.. (2023). Hepatic Transcriptomics Reveals Reduced Lipogenesis in High-Salt Diet Mice. Genes. 14(5). 966–966. 2 indexed citations
3.
Zhou, Bing, et al.. (2023). Whole-genome DNA methylation and gene expression profiling in the livers of mice with nonalcoholic steatohepatitis. Life Sciences. 329. 121951–121951. 7 indexed citations
4.
Li, Bo, Ziyi Yang, Fei Mao, et al.. (2023). Downregulation of microRNA-145a-5p promotes steatosis-to-NASH progression through upregulation of Nr4a2. Journal of Hepatology. 79(5). 1096–1109. 10 indexed citations
5.
Mao, Fei, Jing Xu, Jinmiao Lu, et al.. (2022). Transcriptome Analysis of Multiple Metabolic Tissues in High-Salt Diet–Fed Mice. Frontiers in Endocrinology. 13. 887843–887843. 5 indexed citations
6.
Xu, Jing & Fei Mao. (2021). Role of high-salt diet in non-alcoholic fatty liver disease: a mini-review of the evidence. European Journal of Clinical Nutrition. 76(8). 1053–1059. 7 indexed citations
7.
Xiang, Liping, et al.. (2021). Comparison of hepatic gene expression profiles between three mouse models of Nonalcoholic Fatty Liver Disease. Genes & Diseases. 9(1). 201–215. 16 indexed citations
8.
Hodi, F. Stephen, Anita Giobbie‐Hurder, Xiaocheng Wang, et al.. (2019). The Impact of High-Dose Glucocorticoids on the Outcome of Immune-Checkpoint Inhibitor–Related Thyroid Disorders. Cancer Immunology Research. 7(7). 1214–1220. 49 indexed citations
9.
Mao, Fei, Xiaoming Zhu, Bin Lü, & Yiming Li. (2018). Detection of relationships between SUDOSCAN with estimated glomerular filtration rate (eGFR) in Chinese patients with type 2 diabetes. Diabetes Research and Clinical Practice. 138. 113–118. 7 indexed citations
10.
Mao, Fei, Xiaoming Zhu, Siying Liu, et al.. (2018). Age as an Independent Risk Factor for Diabetic Peripheral Neuropathy in Chinese Patients with Type 2 Diabetes. Aging and Disease. 10(3). 592–592. 35 indexed citations
11.
Zhu, Xiaoming, et al.. (2017). Association of SUDOSCAN Values with Vibration Perception Threshold in Chinese Patients with Type 2 Diabetes Mellitus. International Journal of Endocrinology. 2017. 1–5. 7 indexed citations
12.
Liu, Siying, Hangping Zheng, Xiaoming Zhu, et al.. (2017). Neutrophil-to-lymphocyte ratio is associated with diabetic peripheral neuropathy in type 2 diabetes patients. Diabetes Research and Clinical Practice. 130. 90–97. 72 indexed citations
13.
Mao, Fei, Siying Liu, Xiaona Qiao, et al.. (2017). SUDOSCAN, an effective tool for screening chronic kidney disease in patients with type 2 diabetes. Experimental and Therapeutic Medicine. 14(2). 1343–1350. 18 indexed citations
14.
Mao, Fei, Siying Liu, Xiaona Qiao, et al.. (2016). Sudoscan is an effective screening method for asymptomatic diabetic neuropathy in Chinese type 2 diabetes mellitus patients. Journal of Diabetes Investigation. 8(3). 363–368. 46 indexed citations
15.
Li, Junfeng, Zhaoyun Zhang, Xiaoxia Liu, et al.. (2015). Study of GABA in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics. Frontiers in Pharmacology. 6. 260–260. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026